Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Creative Medical Technology Holdings (CELZ) Shares Repurchased (2023 - 2025)

Creative Medical Technology Holdings has reported Shares Repurchased over the past 3 years, most recently at $10000.0 for Q1 2025.

  • Quarterly Shares Repurchased fell 87.92% to $10000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Dec 2025, down 94.28% year-over-year, with the annual reading at $10000.0 for FY2025, 94.28% down from the prior year.
  • Shares Repurchased was $10000.0 for Q1 2025 at Creative Medical Technology Holdings, down from $25450.0 in the prior quarter.
  • Over five years, Shares Repurchased peaked at $191780.0 in Q3 2023 and troughed at $10000.0 in Q1 2025.
  • The 3-year median for Shares Repurchased is $72945.0 (2023), against an average of $75986.0.
  • Biggest five-year swings in Shares Repurchased: tumbled 86.73% in 2024 and later crashed 87.92% in 2025.
  • Tracing CELZ's Shares Repurchased over 3 years: stood at $79172.0 in 2023, then crashed by 67.85% to $25450.0 in 2024, then crashed by 60.71% to $10000.0 in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $10000.0, $25450.0, and $66718.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.